Global Infant Phototherapy Lamps Market - 2022-2029

Global Infant Phototherapy Lamps Market - 2022-2029

Market Overview

The global infant phototherapy lamps market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Phototherapy involves shining fluorescent lights from bili-light lamps on newborns' bare skin. This therapy uses a specific wavelength of light to break down bilirubin into a form that the body can eliminate through urine and stool.

Market Dynamics

The factors influencing the global infant phototherapy lamps market are the increasing demand for phototherapy lamps and the growing prevalence of jaundice.

The increasing demand for phototherapy lamps for infants is expected to drive the market growth

Phototherapy is a type of light therapy used to treat jaundice in newborns. Because of a pigment called bilirubin, jaundice causes a yellowish discoloration of the skin and eyes in newborns. At least 60% of babies are born with jaundice. However, a few babies' bilirubin levels are high enough at birth to cause brain damage. The cause could be a birth infection, low birth weight, or breast milk. By making excess bilirubin (yellow substance), water-soluble phototherapy aids your baby's body get rid of it. This makes it easier for your baby's liver to break down bilirubin in their blood and remove it through urine and stools.

Phototherapy uses a specific type of light rather than ultraviolet light. Phototherapy involves shining fluorescent lights from bili-light lamps on newborns' bare skin. This therapy uses a specific wavelength of light to break down bilirubin into a form that the body can eliminate through urine and stool. It has a blue appearance and may emit light with 430-490 nm wavelength in the blue-green spectrum. This therapy is performed using a bili-light lamp or a bili-blanket. For the prevention and treatment of neonatal hyperbilirubinemia, phototherapy (PT) with white (daylight) or monochromatic (blue light) lamps is widely used. Except for exchange-transfusion, PT has the following advantages it is inexpensive and simple to use; the breakdown products of bilirubin are not toxic to the CNS and are quickly eliminated through the kidneys and liver, and it is the most effective of all modes of prevention and treatment of neonatal hyperbilirubinemia. Moreover, according to the American Academy of Pediatrics (AAP), a newborn with jaundice and a very high bilirubin level in the blood (hyperbilirubinemia) of 18 mg/dL should have the bilirubin level reduced to 13-14 mg before phototherapy is stopped.

Limitations associated with phototherapy lamps are expected to hamper the market growth

Phototherapy isolates the child from their mother, disrupting maternal-child bonding. It can affect the neonate's auditory and visual alertness and cause anxiety in the parents. In cluster interactive processes, neonates who received phototherapy had significantly poorer orientation responses to visual inanimate, visual animate, and visual and auditory animates, according to Abrol P. et al. According to Olusanya BO. et al., 36 percent of mothers prefer filtered sunlight phototherapy because it allows them to feed and bond with their children while receiving treatment instead of traditional phototherapy, which requires them to be separated. Interrupted phototherapy may play an important role in increasing maternal-neonatal interaction and allowing skin-to-skin contact and breastfeeding during phototherapy management. Due to bilirubin's bowel irritation, some neonates may experience loose stools while on phototherapy, contributing to water loss. If possible, breastfeeding should be continued, and fluid resuscitation should be started if necessary.

COVID-19 Impact Analysis

Several studies have been conducted to identify potential therapeutic interventions for critically ill COVID-19 patients since the emergence of the COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, many of these interventions have failed to show promising results in human clinical trials. Ultraviolet-A (UVA) light therapy treats various dermatological complications in many clinical settings. UVA light has also been antimicrobial properties in several preclinical studies. In this context, studies have found that exposing coronavirus-229E transfected human tracheal cells to UVA light activates mitochondrial antiviral signaling protein (MAVS), which reduces viral spike protein expression and restores infected cell proliferation. The current study investigated the safety and therapeutic effects of applying UVA light to critically ill COVID-19 patients through the endotracheal tube. Hence, the increasing use of phototherapy lamps is expected to drive market growth.

Segment Analysis

Fluorescent Lamps segment is expected to dominate the market growth

The use of bili lights to shine a fluorescent light on bare skin is known as phototherapy. Bilirubin can be broken down into a form that the body can eliminate through urine and stools by using a specific wavelength of light. The light appears to be blue. The newborn is placed under the lights naked or with only a diaper on. The blue fluorescent Bili lamps emit specific wavelengths of blue light that aid in the breakdown of bilirubin into nontoxic substances that can be excreted via urine and stools. For phototherapy, blue fluorescent tubes are commonly used. Narrow-spectrum blue lamps (special blue) appear to be the most effective, while ordinary blue fluorescent lamps are likely to be equivalent to standard white daylight lamps. Hospital staff may be bothered by blue lights, which can be alleviated by mixing blue and white tubes in the phototherapy unit. White (daylight) fluorescent tubes are less efficient than special blue lamps; however, by reducing the distance between infants and the lamps, this inefficiency can be compensated for. The use of reflective materials is also beneficial. White lamps provide effective phototherapy in LMICs where the cost of special blue lamps may be prohibitive.

Geographical Analysis

North America region is expected to hold the largest market share in the global infant phototherapy lamps market

The growing prevalence of jaundice and increasing demand for infant phototherapy lamps are expected to drive the market growth.

Jaundice affects approximately 50% of term and 80% of preterm infants within the first 2-4 days of life in the United States. Because almost every newborn develops an unconjugated serum bilirubin level of more than 30 mol/L (1.8 mg/dL) during the first week, neonatal hyperbilirubinemia is extremely common. The National Institute of Child Health and Development in the United States conducted a multicenter study of phototherapy on newborns with jaundice. When bilirubinemia was above 13mg/dl, with an average of 15mg/d, phototherapy was used continuously in those weighing more than 2500 grams (140 NBs). The babies were 60 hours old on average. The fluorescent daylight equipment was used for 2000 hours at an average irradiance of 14 mm/cm2/nm; bilirubinemia levels in newborns treated with phototherapy were significantly lower than those in the control group.

Competitive Landscape

The global infant phototherapy lamps market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Atom Medical Corporation, AVI Healthcare Pvt. Ltd., Equalize Health, Inc., General Electric Company, Ibis Medical Equipment & Systems Pvt. Ltd., Natus Medical Incorporated, Ningbo David Medical Device Co., LTD., Novos Medical Devices San. Tic. Imp & Ihr. Ltd. Sti., Weyer GmbH, Zhengzhou Dison Instrument, and Meter Co., Ltd.

Atom Medical Corporation

Overview: Atom Medical Corporation is into medical equipment manufacturing, distribution, export, and import (obstetric and gynecological equipment, equipment for neonatal and infants, infusion equipment, respiratory apparatus, nursing wards, and disposable medical products). It was founded in 1948.

Product Portfolio: BILI-THERAPY Type of Spot. Three different LED phototherapy units are available, depending on the clinical situation. The unit can be mounted on the F-Rail around the incubator or warmer.

Why Purchase the Report?

visualize the composition of the global infant phototherapy lamps market segmentation by light source and end user highlighting the key commercial assets and players.

Identify commercial opportunities in global infant phototherapy lamps market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global infant phototherapy lamps market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global infant phototherapy lamps market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers